Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin

Virology

Volumn 417, Issue 1, 2011, Pages 50-56

  Watanabe, Rie ^a,b   Leser, George P ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

BST2; CD317; Influenza virus; Restriction factors; Tetherin; Virus restriction; Virus like particles

Indexed keywords

CELL PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE CONSTRUCT; HUMAN; HUMAN CELL; INFLUENZA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLAQUE FORMING CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRION; VIROGENESIS; VIRUS ENTRY; VIRUS LIKE AGENT; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; ANTIGENS, CD; CELL LINE; DOGS; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; ORTHOMYXOVIRIDAE; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS 1; ORTHOMYXOVIRIDAE;

EID: 80054992566     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.05.006     Document Type: Article

References (39)

1. Bavari S., Bosio C.M., Wiegand E., Ruthel G., Will A.B., Geisbert T.W., Hevey M., Schmaljohn C., Schmaljohn A., Aman M.J. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 2002, 195:593-602. (PMC2193767).
2. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., Adams D.J., Xavier R.J., Farzan M., Elledge S.J. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254. (PMC2824905).
3. Chen B.J., Leser G.P., Jackson D., Lamb R.A. The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J. Virol. 2008, 82:10059-10070. (PMC2566248).
4. Chen B.J., Leser G.P., Morita E., Lamb R.A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 2007, 81:7111-7123. (PMC1933269).
5. Choppin P.W. Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology 1969, 39:130-134.
6. Ehrhardt C., Seyer R., Hrincius E.R., Eierhoff T., Wolff T., Ludwig S. Interplay between influenza A virus and the innate immune signaling. Microbes Infect. 2010, 12:81-87.
7. Evans D.T., Serra-Moreno R., Singh R.K., Guatelli J.C. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends. Microbiol. 2010, 18:388-396.
8. Gupta R.K., Mlcochova P., Pelchen-Matthews A., Petit S.J., Mattiuzzo G., Pillay D., Takeuchi Y., Marsh M., Towers G.J. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20889-20894. (PMC2791628).
9. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of infuenza virus. J. Gen. Virol. 2008, 89:2359-2376.
10. Iwabu Y., Fujita H., Kinomoto M., Kaneko K., Ishizaka Y., Tanaka Y., Sata T., Tokunaga K. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 2009, 284:35060-35072. (PMC2787367).
11. Jia B., Serra-Moreno R., Neidermyer W., Rahmberg A., Mackey J., Fofana I.B., Johnson W.E., Westmoreland S., Evans D.T. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009, 5:e1000429. (PMC2673686).
12. Jouvenet N., Neil S.J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 83:1837-1844. (PMC2643743).
13. Kaletsky R.L., Francica J.R., Agrawal-Gamse C., Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2886-2891. (PMC2650360).
14. Kawai S., Azuma Y., Fujii E., Furugaki K., Ozaki S., Matsumoto T., Kosaka M., Yamada-Okabe H. Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci. 2008, 99:2461-2466.
15. Kupzig S., Korolchuk V., Rollason R., Sugden A., Wilde A., Banting G. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003, 4:694-709.
16. Le Tortorec A., Neil S.J. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 2009, 83:11966-11978. (PMC2772693).
17. Leser G.P., Lamb R.A. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 2005, 342:215-227.
18. Lindwasser O.W., Resh M.D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 2001, 75:7913-7924.
19. Mansouri M., Viswanathan K., Douglas J.L., Hines J., Gustin J., Moses A.V., Fruh K. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83:9672-9681. (PMC2748026).
20. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirs release and is antagonized by HIV-1 Vpu. Nature 2008, 451:406-408.
21. Nemeroff M.E., Barabino S.M., Li Y., Keller W., Krug R.M. Influenza virus NS1 protein interacts with the cellular 30kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol. Cell 1998, 1:991-1000.
22. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272. (PMC111827).
23. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13925-13930.
24. Pawliczek T., Crump C.M. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J. Virol. 2009, 83:11254-11264. (PMC2772754).
25. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., Bieniasz P.D. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511. (PMC2844890).
26. Radoshitzky S.R., Dong L., Chi X., Clester J.C., Retterer C., Spurgers K., Kuhn J.H., Sandwick S., Ruthel G., Kota K., Boltz D., Warren T., Kranzusch P.J., Whelan S.P., Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 2010, 84:10569-10580. (PMC2950602).
27. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 2009, 83:2382-2385. (PMC2643706).
28. Scheiffele P., Rietveld A., Wilk T., Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 1999, 274(4):2038-2044.
29. Schmitt A.P., Leser G.P., Morita E., Sundquist W.I., Lamb R.A. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 2005, 79:2988-2997. (PMC548478).
30. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 2003, 9:1404-1407.
31. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
32. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14764-14769. (PMC25111).
33. Takeda M., Leser G.P., Russell C.J., Lamb R.A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14610-14617. (PMC299746).
34. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Stephens E.B., Guatelli J.C. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
35. Wang X., Hinson E.R., Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2:96-105.
36. Watanabe R., Lamb R.A. Influenza virus budding does not require a functional AAA+ATPase, VPS4. Virus Res. 2010, 153:58-63. (PMC3059594).
37. Weidner J.M., Jiang D., Pan X.B., Chang J., Block T.M., Guo J.T. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 2010, 84:12646-12657. (PMC3004348).
38. Yondola M.A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 2011, 85:2480-2491.
39. Zhao C., Hsiang T.Y., Kuo R.L., Krug R.M. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2253-2258. (PMC2836655).